The management of hepatocellular carcinoma (HCC) has become ever more demanding To evaluate the available evidence and to give clinicians the best guidance, all major hepatology societies have developed guidelines for HCC Recently, updated versions have been published by the American, the Asian Pacific, and the European societies This article presents a comparison of these three guidelinesResults Eightyfour (70%) nodules were HCC the radiological diagnosis was done in 38 (%) of those 12cm and in 38 (95%) for those >2cm HCCs according to 10 AASLD criteria CT or MRI detected 13 HCC nodules that were missed by unenhanced US Despite an absolute specificity, CEUS failed to identify any HCC uncharacterized by CT or MRI By updated AASLD criteria, 6 (17%) FNB procedures were spared in patients with 12cm nodules (p=0025), as compared to 05 criteria1 Introduction The guidelines published in 05 by the American Association for the Study of Liver Diseases (AASLD) on the management of hepatocellular carcinoma (HCC) in cirrhosis recommend a therapeutic algorithm based on patients' stratification in the Barcelona Clinic Liver Cancer system (BCLC) stages , The BCLC, introduced in 1999 and updated in 10 , , still
Pdf sld Practice Guideline Management Of Hepatocellular Carcinoma An Update
